Lucid Diagnostics to Engage at the Maxim Growth Summit 2025 in New York Lucid Diagnostics, a leader in cancer prevention, will attend the 2025 Maxim Growth Summit in New York. Key meetings with investors are planned.

Lucid Diagnostics to Engage at the Maxim Growth Summit 2025 in New York #United_States #New_York #Lucid_Diagnostics #PAVmed_Inc #Maxim_Growth

Lucid Diagnostics Reveals Plans For New Public Stock Offering to Boost Cancer Detection Efforts Lucid Diagnostics has announced its intention to offer common stock in a public offering to enhance its cancer prevention capabilities. Major underwriters will assist in the process.

Lucid Diagnostics Reveals Plans For New Public Stock Offering to Boost Cancer Detection Efforts #United_States #New_York #Lucid_Diagnostics #Esophageal_Cancer #PAVmed_Inc

Lucid Diagnostics Announces Pricing for New Public Stock Offering as Growth Strategy Continues Lucid Diagnostics has set the price for its public stock offering aimed at supporting cancer prevention efforts. This move is seen as a critical step for the company's growth.

Lucid Diagnostics Announces Pricing for New Public Stock Offering as Growth Strategy Continues #United_States #New_York #Lucid_Diagnostics #EsoGuard_Test #PAVmed_Inc